Compound information
- Natural Products
- ZC1889589
- Molecular Formula
- C19H28N2O3
- Molecular Weight
- 332.209992756 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1R)-1-(cyclohexylcarbamoyl)-2-methyl-propyl]carbamate
- InChI
- InChI=1S/C19H28N2O3/c1-14(2)17(18(22)20-16-11-7-4-8-12-16)21-19(23)24-13-15-9-5-3-6-10-15/h3,5-6,9-10,14,16-17H,4,7-8,11-13H2,1-2H3,(H,20,22)(H,21,23)/t17-/m1/s1
- InChI Key
- UQBYHYLSJXPFLH-QGZVFWFLSA-N
- SMILES
- CC(C)[C@@H](NC(=O)OCc1ccccc1)C(=O)NC1CCCCC1
- Source
- ZINC000000346072
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 67.43 Å2 | LogP | 3.869 |
LogS | -3.885 | LogD | 3.846 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.125 | Pgp substrate | 0.841 |
HIA | 0.969 | F20 % | 0.995 |
F30 % | 0.526 | Caco-2 | -4.667 |
MDCK | -4.715 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.597 | PPB | 75.347 |
VD | 0.708 | Fu | 1.089 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.433 | CYP1A2 substrate | 0.456 |
CYP2A6 substrate | 0.691 | CYP2B6 substrate | 0.591 |
CYP2C19 inhibitor | 0.925 | CYP2C19 substrate | 0.752 |
CYP2C8 substrate | 0.626 | CYP2C9 inhibitor | 0.489 |
CYP2C9 substrate | 0.812 | CYP2D6 inhibitor | 0.017 |
CYP2D6 substrate | 0.262 | CYP2E1 substrate | 0.161 |
CYP3A4 inhibitor | 0.974 | CYP3A4 substrate | 0.587 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.587 | CL | 4.47 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.105 | Hepatotoxicity | 0.592 |
Mutagenicity | 0.009 | Rat Oral Acute Toxicity | 0.43 |
FDAMDD | 0.146 | Skin Sensitization | 0.003 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.002 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.01 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.216 | IGC50 | 3.981 |
LC50FM | 4.189 | LC50DM | 4.911 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.136 | NR-AR-LBD | 0.217 |
NR-AhR | 0.004 | NR-Aromatase | 0.051 |
NR-ER | 0.269 | NR-ER-LBD | 0.321 |
NR-PPAR-gamma | 0.281 | SR-ARE | 0.127 |
SR-ATAD5 | 0.301 | SR-HSE | 0.175 |
SR-MMP | 0.027 | SR-p53 | 0.038 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.